These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Achromobacter xylosoxidans mesh related infection: a case of delayed diagnosis and management. Gupta V; Nirkhiwale S; Gupta P; Phatak S J Infect; 2012 Mar; 64(3):e1-5. PubMed ID: 21959012 [TBL] [Abstract][Full Text] [Related]
5. Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis. Talbot NP; Flight WG Paediatr Respir Rev; 2016 Aug; 20 Suppl():27-9. PubMed ID: 27374622 [TBL] [Abstract][Full Text] [Related]
7. Achromobacter xylosoxidans Bacteremia and Cellulitis: A Report of a Case. Dai J; Huen AO; Kestenbaum LA; Sarezky MD; Coughlin CC; Yan AC Pediatr Dermatol; 2015; 32(4):e186-7. PubMed ID: 25973735 [TBL] [Abstract][Full Text] [Related]
9. Clinical, microbiological profile and treatment outcome of ocular infections caused by Achromobacter xylosoxidans. Reddy AK; Garg P; Shah V; Gopinathan U Cornea; 2009 Dec; 28(10):1100-3. PubMed ID: 19730091 [TBL] [Abstract][Full Text] [Related]
10. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Bador J; Amoureux L; Blanc E; Neuwirth C Antimicrob Agents Chemother; 2013 Jan; 57(1):603-5. PubMed ID: 23089757 [TBL] [Abstract][Full Text] [Related]
11. Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections. Warner NC; Bartelt LA; Lachiewicz AM; Tompkins KM; Miller MB; Alby K; Jones MB; Carr AL; Alexander J; Gainey AB; Daniels R; Burch AK; Brown DE; Brownstein MJ; Cheema F; Linder KE; Shields RK; Longworth S; van Duin D Clin Infect Dis; 2021 Oct; 73(7):e1754-e1757. PubMed ID: 33313656 [TBL] [Abstract][Full Text] [Related]
12. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. Wang JH; Lin PC; Chou CH; Ho CM; Lin KH; Tsai CT; Wang JH; Chi CY; Ho MW J Microbiol Immunol Infect; 2014 Jun; 47(3):204-10. PubMed ID: 23201321 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of severe neurosurgical patients with pyogenic ventriculitis caused by gram-negative bacteria. Shang F; Xu Y; Wang N; Cheng W; Chen W; Duan W Neurol Sci; 2018 Jan; 39(1):79-84. PubMed ID: 29027589 [TBL] [Abstract][Full Text] [Related]
14. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Tängdén T; Enblad P; Ullberg M; Sjölin J Clin Infect Dis; 2011 Jun; 52(11):1310-6. PubMed ID: 21540208 [TBL] [Abstract][Full Text] [Related]